mean utility measured with EQ-5D was 0.487 (0.919 to -0.594), and the mean EDSS score 5.1 (1.0 to 9.5). All costs (direct … care related to their MS. Disease scores (Expanded Disability Status Scale, EDSS) were available for a majority of patients … from the study centers, and were assigned using a matrix of disease (mobility) descriptions and EDSS scores. Mean total …

Disability Status Scale, EDSS) were available from the study centers. For the remainder, disease scores were assigned using a … matrix of disease (mobility) descriptions and EDSS scores. Mean total cost per patient and year was 65,400 DM, adjusted for … mean age of the cohort was 42 years (disease onset 33), the mean utility measured with EQ-5D was 0.552 (0.919 to -0 …

mean utility measured with EQ-5D was 0.487 (0.919 to -0.594), and the mean EDSS score 5.1 (1.0 to 9.5). All costs (direct … care related to their MS. Disease scores (Expanded Disability Status Scale, EDSS) were available for a majority of patients … from the study centers, and were assigned using a matrix of disease (mobility) descriptions and EDSS scores. Mean total …

Disability Status Scale, EDSS) were available from the study centers. For the remainder, disease scores were assigned using a … matrix of disease (mobility) descriptions and EDSS scores. Mean total cost per patient and year was 65,400 DM, adjusted for … mean age of the cohort was 42 years (disease onset 33), the mean utility measured with EQ-5D was 0.552 (0.919 to –0 …

years (disease onset 34), the mean utility measured with EQ-5D was 0.487 (0.919 to –0.594), and the mean EDSS score 5.1 (1 … absence and informal care related to their MS. Disease scores (Expanded Disability Status Scale, EDSS) were available for a … majority of patients from the study centers, and were assigned using a matrix of disease (mobility) descriptions and EDSS …

-- Costs ; Quality of Life ; Multiple Sclerosis …

, using main diagnosis to calculate costs, showed the total cost to be 1 736 MSEK. Increased disability as measured by EDSS … care costs rose significantly with increased EDSS and were higher during a relapse. Quality of life declined substantially … with increased EDSS and was lower during a relapse. In summary, this study showed that a severe, chronic, disabling disease …

endpoints including survival of patients without their disease getting worse (i.e., progression-free survival). Also …